<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03476772</url>
  </required_header>
  <id_info>
    <org_study_id>NBCH</org_study_id>
    <nct_id>NCT03476772</nct_id>
  </id_info>
  <brief_title>Nalbuphine Plus Caudal Bupivacaine in Hypospadius Repair</brief_title>
  <official_title>Nalbuphine as an Adjuvant to Caudal Bupivacaine for Postoperative Analgesia in Children Undergoing Hypospadius Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Caudal aneasthesia for pediatric surgery was first reported in 1933. Since then, studies have&#xD;
      described the indications for pediatric caudal block, the level of analgesia, doses,&#xD;
      advantages and disadvantages of this technique.&#xD;
&#xD;
      In children, caudal anesthesia is most effectively used as adjunct to general aneasthesia and&#xD;
      has an opioid-sparing effect, permitting faster and smoother emergence from aneasthesia.&#xD;
&#xD;
      A single shot caudal anesthesia provides relatively brief analgesia for 4 to 8 hours&#xD;
      depending on the agent used. Prolongation of anesthesia can be achieved by adding various&#xD;
      adjuvants, such as opioids and nonopioids such as clonidine, ketamine, midazolam, and&#xD;
      neostigmine,with varying degrees of success.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The somatic innervation of the lower urogenital system arises principally from the spinal&#xD;
      nerves sacral 2 to sacral 4 by way of the pudendal nerve. After passing under the&#xD;
      sacrospinous ligament and over the sacrotuberous ligament through Alcock's canal, the&#xD;
      pudendal nerve passes through the transverse perineal muscle to course on the dorsum of the&#xD;
      penis as the dorsal nerve of the penis. The dorsal nerve of the penis is thought to be a&#xD;
      sensory nerve. The autonomic innervation of the penis arises from the vesical and prostatic&#xD;
      plexus, which is composed of sympathetic nerves from lumbar 1 and lumbar 2, and&#xD;
      parasympathetic nerves from sacral 2 to sacral 4. The cavernosal nerve leaves the pelvis&#xD;
      between the transverse perineal muscles and the membranous urethra before passing beneath the&#xD;
      arch of pubis to supply each corporal body.&#xD;
&#xD;
      After the pudendal nerve leaves the pudendal canal, two main terminal branches arise, the&#xD;
      inferior rectal and the perineal nerves. The function of the inferior rectal nerve is motor&#xD;
      innervation of external anal sphincter and is thought to be devoid of urogenital function.&#xD;
      Sensory portions of the inferior rectal nerve are important for perianal skin sensation. The&#xD;
      perineal nerve has both a motor and sensory component. The motor efferents are known to&#xD;
      innervate the pelvic musculature, mainly the bulbospongiosus muscle. To achieve complete&#xD;
      anesthesia (analgesia) for hypospadius repair, afferent blockade must be complete at lumbar 1&#xD;
      through sacral 4.&#xD;
&#xD;
      Nalbuphine is a mixed k-agonist and Âµ-antagonist opioid of the phenanthrene group; it is&#xD;
      related chemically to naloxone and oxymorphone. Nalbuphine leads to activation of spinal and&#xD;
      supraspinal opioid receptors which leads to good analgesia with minimal sedation, minimal&#xD;
      nausea and vomiting, less respiratory depression and stable cardiovascular functions. Safety&#xD;
      and efficacy of nalbuphine have been established in the clinical field and its safety and&#xD;
      efficacy also established via the epidural route. Nalbuphine was also added in epidural&#xD;
      analgesia for adults and provided an increase in the efficacy and the duration of&#xD;
      postoperative analgesia. The effect of nalbuphine addition in caudal anesthesia in pediatrics&#xD;
      is not well established.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post operative pain measurement</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative pain intensity Measured by Face, Legs, Activity, Cry &amp; consolability (FLACC) pain scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>children undergoing hypospadius repair given 1 ml/kg of bupivicaine 0.25 % via caudal route to achieve post operative analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>children undergoing hypospadius repair given 1 ml/kg of bupivicaine 0.25 % plus 0.1 mg nalbuphine via caudal route to achieve post operative analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nalbuphine</intervention_name>
    <description>Children will be randomly assigned into 2 groups of 30 patients each. They will receive caudal anesthesia using bupivacaine 0.25% 1ml/kg plus 2 ml normal saline in the control group, bupivacaine 0.25% 1ml/kg plus nalbuphine 0.1 mg/kg in 2 ml solution in the nalbuphine group.</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male children undergoing hypospadius repair, with an American Society of&#xD;
             Anesthesiologists (ASA) physical status I.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Guardians refusal.&#xD;
&#xD;
          -  Contraindication to caudal block such as:&#xD;
&#xD;
               -  Patients with congenital anomalies at the lower spine or meninges.&#xD;
&#xD;
               -  Patients with increased intracranial pressure.&#xD;
&#xD;
               -  Patients with skin infection at the site of injection.&#xD;
&#xD;
               -  Patients with bleeding diathesis.&#xD;
&#xD;
               -  Know allergy to any drug used in this study.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>SPIEGEL P. Caudal anesthesia in pediatric surgery: a preliminary report. Anesth Analg. 1962 Mar-Apr;41:218-21.</citation>
    <PMID>13915759</PMID>
  </reference>
  <reference>
    <citation>de Beer DA, Thomas ML. Caudal additives in children--solutions or problems? Br J Anaesth. 2003 Apr;90(4):487-98. Review.</citation>
    <PMID>12644422</PMID>
  </reference>
  <reference>
    <citation>Lake CL, Duckworth EN, DiFazio CA, Durbin CG, Magruder MR. Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease. Anesthesiology. 1982 Dec;57(6):498-503.</citation>
    <PMID>6983316</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 9, 2018</study_first_submitted>
  <study_first_submitted_qc>March 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2018</study_first_posted>
  <last_update_submitted>March 21, 2021</last_update_submitted>
  <last_update_submitted_qc>March 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>TKSayed</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

